Surrey research offers new hope for people suffering from immunodeficiencies

Several rare immune disorders are caused by mutations in the patient’s DNA. The University of Surrey and its collaborators found that targeting the mutated pathways with new drugs offers new hope for people suffering from rare conditions such as immunodeficiencies.

Pfizer boasts over 30% increase in Q3 revenues against previous year – Pharmaceutical Technology

Pfizer CEO Dr Albert Bourla presided over an exceptional Q3 amid financial decline and pressure from investor Starboard Value. Credit: Ververidis Vasilis / Shutterstock. Pfizer

October 30, 2024

ASCT Tops CAR T-Cell Therapy for Relapsed LBCL in Complete Remission

SAN DIEGO — Autologous stem-cell transplantation (ASCT) led to improved outcomes as compared with CAR T-cell therapy for patients with relapsed large B-cell lymphoma (LBCL)

December 11, 2023

Advamed report finds racial disparities in care, proposes fixes

Listen to the article 4 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: White Medicare patients are 50%

March 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.